These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17672387)

  • 1. [Positive evaluation in early detection. "Number of intestinal cancer fatalities have decreased by about 3,000 (interview by Dr. Christina Berndt)].
    Birkner B
    MMW Fortschr Med; 2007 Mar; 149(13):6. PubMed ID: 17672387
    [No Abstract]   [Full Text] [Related]  

  • 2. [Screening colonoscopy for early detection of intestinal cancer].
    Mader U
    Dtsch Med Wochenschr; 2003 Mar; 128(12):596. PubMed ID: 12685432
    [No Abstract]   [Full Text] [Related]  

  • 3. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal screening in Germany.
    Pox C; Schmiegel W
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S31-2. PubMed ID: 18368638
    [No Abstract]   [Full Text] [Related]  

  • 5. [Annual occult blood tests lower intestinal cancer mortality].
    Gnauck R
    Wien Med Wochenschr; 1993; 143(13):352. PubMed ID: 8237026
    [No Abstract]   [Full Text] [Related]  

  • 6. Increasing public acceptance for CRC screening through public relation campaigns and networking.
    Maar C
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S35-7. PubMed ID: 18368640
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of colorectal cancer tests--United States, 2002, 2004, and 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):253-8. PubMed ID: 18340331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of health insurance coverage in cancer screening utilization.
    Robinson JM; Shavers V
    J Health Care Poor Underserved; 2008 Aug; 19(3):842-56. PubMed ID: 18677074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
    Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
    Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer mass screening event utilising quantitative faecal occult blood test.
    Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW
    Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening in Scotland.
    Steele RJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S33-4. PubMed ID: 18368639
    [No Abstract]   [Full Text] [Related]  

  • 15. Data sources for measuring colorectal endoscopy use among Medicare enrollees.
    Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2118-27. PubMed ID: 17932360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of screening colonoscopy in a community-based study].
    Hüppe D; Hartmann H; Felten G; Kemen M; Tannapfel A; Gillessen A; Katalinic A
    Z Gastroenterol; 2008 Feb; 46(2):193-200. PubMed ID: 18253898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of the sporadic colorectal cancer].
    Zavoral M; Závada F
    Cas Lek Cesk; 2007; 146(12):950-4. PubMed ID: 18257413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in FOBT use: evidence from a large German survey.
    Sieverding M; Matterne U; Ciccarello L
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S47-51. PubMed ID: 18368645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme.
    Rodger J; Steele RJ
    J Med Screen; 2008; 15(2):105-7. PubMed ID: 18573779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.